Skip to main content
Logo
European Insurance and Occupational Pensions Authority
 

Search QAs

Filter by

Search QAs ()

RSS
Showing results 430 to 440

I have two question regarding how to classify fund's income for S.09.01. As in the guidance, the dividend column is saying it is applicable to Collective Investment Funds but Interest column is not mentioning this is applicable to Collective Investment Funds. (1) in a mutual fund scenario, if the fund is paying interest or dividend depends on the underlying asset composition and economics. If the income is received as interest, should we report interest under dividend column? (2) for other type of Collective Investment fund (CIC 4X) which pays interest income. When they are not re-invested, should the interest income be reported in the interest income in S.09.01, or should it be reported in Dividend.

Topics:
  • Reporting Templates

We understand that taxes or levies are included in the best estimate of technical provisions only if they are imposed on the policyholder or arise in the settlement of the policy (hereinafter referred to as transaction-based taxes or levies). Therefore, we believe that if a particular tax or levy is not a transaction-based tax or levy, it should not be included in the best estimate of technical provisions.

Topics:
  • Technical Provisions (TPs)

Is ACTION LOGEMENT SERVICES, which is listed in the INSEE list of central administration organisms subject to SCR spread 0 calculation under b of 2 of Article 180 of the delegated regulation 2015/35 ?

Risk concentrations for Unit Linked, cell C0200 May Swedish undertakers have exception to report risk concentrations on Unit Linked products since the risk is fully borne by the policy holder? hall there be reporting in cell C0200 even if it does not entail any concentrations risk for the insurance undertaker?

Topics:
  • Reporting Templates

Can you please confirm the presentation of the expected reimbursement of re-insured claims that are past due but not yet paid to the policyholder. In particular whether these amounts are presented in reinsurance recoverable or reinsurance receivable.

Topics:
  • Reporting Templates

When considering an exposure to be a significant RC (that represent 10% of the group SCR) is it to be compared with C0150 Total amount of the exposure (gross) or Amount of exposures… (net) to the group SCR?

Topics:
  • Reporting Templates

Template S.06.02:

C0293 = how to properly fill in this field and where can we find the information?
C0296 and C0297 = should we interpret that CIC 95 should be classified as 9 and how to handle land and leases or rights of use.

Topics:
  • Reporting Templates

We would like to clarify what exactly needs to be included for S.06.02 C0295 Crypto-assets. Are only directly held crypto assets to be included? EIOPA Q&A 2654 seems to indicate that only directly held crypto assets are to be included as per “if C0295 Crypto-assets has been completed with 1-4, then CIC code should be 'XX09'”. But does this new field consider non-direct exposure. For example how should the below be reported in this field: Equity of a large cryptocurrency exchange platform be included? Typically CIC3 e.g. ISIN US19260Q1076 A collective investment fund that tracks bitcoin. Typically CIC4 e.g. ISIN DE000A27Z304

Topics:
  • Reporting Templates

1. Future Premiums for the Premium Provision Calculation under Solvency II: We have a question regarding the calculation of premium provisions. The present value of future premiums is a component of this calculation, and we would like to know if this component can be equal to zero other than the case of the premiums being paid fully before the inception of the coverage (considering that the policy is active).

Topics:
  • Technical Provisions (TPs)

For reporting e.g. in S.08.01, if there is no LEI code available, validation rule BV1243 does not allow the item "None" for "counterparty (group) code type". Yet the filing rules do allow that constellation. Could you please check this validation rule or clarify how to report in such cases?

Topics:
  • Validations